Range Impac

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Range Impac and buy or sell other stocks, ETFs, and their options commission-free!

About RNGE

Range Impact, Inc. engages in unlocking the power of cannabinoids for the treatment of serious neurological and inflammatory disorders. It operates through Pharmaceutical Operations and Clinical Operations segments. 

CEO
Michael Cavanaugh
CEOMichael Cavanaugh
Employees
10
Employees10
Headquarters
Cleveland, Ohio
HeadquartersCleveland, Ohio
Founded
2007
Founded2007
Employees
10
Employees10

RNGE Key Statistics

Market cap
107.68M
Market cap107.68M
Price-Earnings ratio
8.28
Price-Earnings ratio8.28
Dividend yield
Dividend yield
Average volume
115.72K
Average volume115.72K
High today
High today
Low today
Low today
Open price
$0.921
Open price$0.921
Volume
0.00
Volume0.00
52 Week high
$0.94
52 Week high$0.94
52 Week low
$0.1206
52 Week low$0.1206

Stock Snapshot

Range Impac(RNGE) stock is priced at $0.90, giving the company a market capitalization of 107.68M. It carries a P/E multiple of 8.28.

On 2026-07-14, Range Impac(RNGE) shares started trading at $0.92, with intraday highs of — and lows of —.

Trading activity shows a volume of 0, compared to an average daily volume of 115.72K.

The stock's 52-week range extends from a low of $0.12 to a high of $0.94.

The stock's 52-week range extends from a low of $0.12 to a high of $0.94.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.